Abstract
Prior research has suggested absence of benefit from tamsulosin, an alpha-1A antagonist, for facilitating passage of ureteral stones <10 mm in size (NEJM JW Gen Med Jul 1 2015 and Lancet 2015; 386:341). Now, investigators conducted a systematic review and meta-analysis of randomized controlled trials of tamsulosin, stratifying the results by stone size (<4 …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
